SAN DIEGO, May 17, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced that Christopher J.

SAN DIEGO, May 16, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced a late-breaking poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 15th

SAN DIEGO, May 15, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced an agreement with UK-based Angel Biomedical Limited, a subsidiary of Angel Biotechnology Holdings

SAN DIEGO, May 15, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today presented its financial results for the first quarter ended March 31, 2012, and other recent developments. (Logo:

SAN DIEGO, April 19, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) is currently exhibiting its new FDA-cleared Excellagen(®) professional-use, syringe-based wound care product